Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @INVIVOnow
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @INVIVOnow
-
New Business Models Are Needed To Support Innovative Payer Partnerships Maximizing patient access to innovative and effective treatments will require increased transparency, improved outcomes data analyses, dynamic contract management and... http://bit.ly/2GZBdrY
#InVivoHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Global Biopharma R&D Productivity And Growth Ranking An analysis of the R&D productivity of the world’s 30 largest public pharmaceutical companies reveals an overall drop in R&D... Related Stories In Vivo's Rough Guide On The State Of RNAi http://bit.ly/2tBYcWY
#InVivoHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Partnerships in
#lifesciences will help advance medicines but who do you think should take home the top spot in the 12th annual#DealsOfTheYear Contest? Click here to vote for the top Alliance Deal: http://bit.ly/2uF0iW4 pic.twitter.com/StPBwmNOo7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Discover new opportunities for
#marketing success with partnering with the industry experts that#pharma leaders trust and rely on. Click to download your media kit here http://bit.ly/31bhAGr pic.twitter.com/WznXWNfFnk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Who do you think deserves to win the
#DealOfTheYear for M&A?
Roche/Spark
AbbVie/Allergan
Bristol-Meyers-Squibb/Celgene
3M/Acelity
Sumitomo Dainippon/Five Roivant Sciences Divisions
Caste your vote here: http://bit.ly/2Gw5QES pic.twitter.com/Sltfb2CgG0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In Vivo's Rough Guide On The State Of RNAi The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold... Related Stories 2019’s Top Biopharma Deal-Makers Deals http://bit.ly/2GSrfIN
#InVivoHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Wondering how you will fill your pipeline & hit your sales numbers in 2020? By partnering with
#PharmaIntelligence, you can generate high quality leads, fill your pipeline & create bespoke#thoughtleadership. Find out more here http://bit.ly/2RGhLq0 pic.twitter.com/V6vkPao1pf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It is that time of year again! It is time to vote in the 12th annual
#DealsOfTheYear contest! We have chosen 15 nominees across 3 categories: Financing, M&A & Alliance. Caste your vote here http://bit.ly/2GwTxIv pic.twitter.com/Exk8PWnJnp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Did you get your entry in for the 2020
#CitelineAwards? Have you seen our illustrious judging panel who will choosing the finalists & winners! Take a look here to read more http://bit.ly/2tX2hoL pic.twitter.com/Dn0JK5Axc2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our
#sponsorship packages offer unique marketing opportunities, ranging from category sponsorship to the prestigious headline sponsor. Find out how you can cement your position in the clinical R&D sector http://bit.ly/2RTknQn#CitelineAwardspic.twitter.com/a3j5hli7VJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
C-Suite Snippets: US Generics Industry Under Pressure In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo. Related Stories Execs On The Move, January 2020 In Vivo's Top M&A Of http://bit.ly/36kP4Dd
#InVivoHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CNS Biomarkers: Monument Targets Schizophrenia, Anxiety And Cognitive Decline Steven Powell, chair of the board at Cambridge Cognition, talks about the group’s latest spin-off company, Monument Therapeutics. Related Stories Connected http://bit.ly/2Gnj0nz
#InVivoHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Connected Strategies Are Vital For Medtechs In The Consumer-Led 2020s Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the... Related Stories Internal Manufacturing http://bit.ly/38pagcG
#InVivoHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESG In 2020: Not A Tick-Box Exercise But A Strategic Opportunity The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure... Related Stories Bayer US http://bit.ly/2ur7o05
#InVivoHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ENTRY DEADLINE EXTENSION! Missed Friday's entry deadline for the 2020
#CitelineAwards? We have extended the entry deadline for the 2020#CitelineAwards until Friday January 24th 2020! Don't miss out and get your entries in now! http://bit.ly/2tAhA6C pic.twitter.com/SKw7TytQAz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Internal Manufacturing Capabilities Are Critical To Level-Up eTheRNA A year into his role as a CEO of the Belgian mRNA biotech eTheRNA immunotherapies, industry veteran Steven Powell talks... Related Stories C-Suite Snippets: Meindert http://bit.ly/3asuQL5
#InVivoHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Execs On The Move, January 2020 An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries. Related Stories In Vivo's Top M&A Of 2019: Cast Your Vote! In Vivo's http://bit.ly/2v6P2lD
#InVivoHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In Vivo's Top M&A Of 2019: Cast Your Vote! It is time for In Vivo's 12th annual Deals of the Year contest. We've selected 15 nominees in three categories... Related Stories In Vivo's Top Financing Of 2019: Cast Your Vote! When Will POC http://bit.ly/2FRMzxs
#InVivoHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In Vivo's
#Outlook2020, includes new chapters on strategy &#DigitalTransformation and what they mean for the#biopharma and#medtech industries. Click to download your copy here and delve into the future: http://bit.ly/303nZTr pic.twitter.com/FsyPQj6cod
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
When Will POC Really Be On The Cusp Of Major Uptake? Point-of-care/near-patient testing has been “two years away from major breakthrough” for at least two decades, but fast access to data... Related Stories In Vivo's Top Alliance Of 2019: http://bit.ly/2RjxHgz
#InVivoHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.